52
Participants
Start Date
August 23, 2023
Primary Completion Date
January 21, 2025
Study Completion Date
April 8, 2025
Aflibercept
Anti-VEGF control
foselutoclax
Experimental drug
Erie Retina Research, LLC, Erie
Vision Research Solutions, PLLC, Philadelphia
Cumberland Valley Retina Consultants, Hagerstown
Retina Consultants of Carolina, Greenville
Florida Eye Associates, Melbourne
Rand Eye Institute, Deerfield Beach
Retina Vitreous Associates of Florida, St. Petersburg
Midwest Eye, Carmel
University Retina and Macula Associates, Lemont
Retina Center of Texas, Southlake
Austin Retina Associates, Round Rock
Retina Research Institution of Texas, Abilene
Advanced Vision Research Institute, Longmont
Sierra Eye Associates, Reno
Retina-Vitreous Associates Medical Group, Beverly Hills
Salehi Retina Institute Inc., Huntington Beach
California Retina Consultants, Bakersfield
Bay Area Retina Associates, Walnut Creek
EyeHealth Northwest, Portland
Unity Biotechnology, Inc.
INDUSTRY